VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $445,000 | -89.3% | 111,808 | -86.6% | 0.01% | -89.3% |
| Q2 2022 | $4,142,000 | -17.7% | 833,333 | 0.0% | 0.08% | -8.5% |
| Q1 2022 | $5,033,000 | -48.0% | 833,333 | 0.0% | 0.08% | -33.9% |
| Q4 2021 | $9,683,000 | -25.9% | 833,333 | 0.0% | 0.12% | -13.9% |
| Q3 2021 | $13,067,000 | -15.9% | 833,333 | 0.0% | 0.14% | -8.3% |
| Q2 2021 | $15,542,000 | -56.7% | 833,333 | 0.0% | 0.16% | -53.3% |
| Q1 2021 | $35,917,000 | – | 833,333 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |